Not A Member?       Forget Password?     
          Click HERE                   Click HERE
   and Register FREE
   LATEST INTERVIEWS
06/25/2009
-
Pharming Group
( OTC:PHGUF ) / Sijmen de Vries
 
06/25/2009
-
Ur-Energy
( AMX:URG ) / Bill Boberg
 
06/24/2009
-
Bioheart, Inc
( NASDAQ:BHRT ) / Dr. Howard J. Leonhardt
 
06/23/2009
-
Alternate Energy Holdings, Inc.
( OTC:AEHI ) / Donald Gillispie
 
06/18/2009
-
Uni-Pixel
( OTCBB:UNXL ) / Reed Killion
 
06/18/2009
-
Cannabis Science, Inc.
( OTCBB:CBIS ) / Steven Kubby
 
06/15/2009
-
UFood Restaurant Group
( OTCBB:UFFC ) / George Naddaff
 
06/08/2009
-
Medical Nutrition USA, Inc.
( NASDAQ:MDNU ) / Frank Newman
 
06/04/2009
-
Butler National Corporation
( OTCBB:BUKS ) / Clark Stewart
 
 
   CEOcast WEEKLY NEWSLETTER  
  
June 29th CEOcast Weekly Newsletter
Companies featured in this edition of the newsletter: ACTC, CBAI, CICS, CVM, DKAM, ICLK, IMUC, ITUI, PHC Markets finished mixed this week, as early sell offs on Monday and Tuesday were recouped later ... Click here for more...
 
   
   STOCKS ON THE MOVE  

PHC, Inc.
 

PHC Announces New Stock Buyback Program
PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE AMEX: PHC), a leading provider of inpatient and outpatient behavioral health services, announced today that its Board of Directors has authorized the buyback of up to 1 million shares of the Companys Class A common stock on the open market over the course of its next fiscal year, which begins July 1, 2009. The current Stock Buyback program, under which the Company has purchased approximately 400,000 shares, expires June 30, 2009.

 

 
Enzo Biochem, Inc.
 

Enzo Biochem Life Sciences Unit Awarded Patent For Increasing Detectability of Proteins and Pathogens
Enzo Biochem, Inc., a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications and laboratory services, announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted a new patent by the U.S. Patent and Trademark Office that will complement existing proprietary technologies that have applications in the molecular diagnostics and life sciences marketplaces.

 

 

 
ImmunoCellular Therapeutics, Ltd
 

ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 For Treatment of Small Cell Lung Cancer
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC - News), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today the issuance of a Japanese patent relating to the companys monoclonal antibody therapeutics. Patent No. 4287147, entitled Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer, covers the use of IMUCs proprietary antibodies in diagnosing and treating patients with small cell lung cancer (SCLC) using the companys lead antibody product candidate, ICT-109............

 

 
     
 
 
Copyright © 2001-2005. All Rights Reserved. Disclaimer | Privacy Policy